Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue

Journal of Molecular Biology

Volumn 326, Issue 5, 2003, Pages 1539-1547

  Ohki, Shin Ya ^a,c   Eto, Masumi ^b   Shimizu, Masato ^a   Takada, Rei ^a   Brautigan, David L ^b   Kainosho, Masatsune ^a  

^a TOKYO METROPOLITAN UNIVERSITY   (Japan)

^b UNIVERSITY OF VIRGINIA   (United States)

^c JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

CPI 17; Myosin phosphatase; NMR structure; Phosphorylation induced conformational change; Vascular smooth muscle contraction

Indexed keywords

ASPARTIC ACID; CPI 17; MYOSIN PHOSPHATASE; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY;

EID: 0037424627     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00048-2     Document Type: Article

References (36)

1. Goldsmith E.J., Sprang S.R., Hamlin R., Xuong N.H., Fletterick R.J. Domain separation in the activation of glycogen phosphorylase a. Science. 245:1989;528-532.
2. Canagarajah B.J., Khokhlatchev A., Cobb M.H., Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell. 90:1997;859-869.
3. Waksman G., Kominos D., Robertson S.C., Pant N., Baltimore D., Birge R.B., et al. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature. 358:1992;646-653.
4. Ranganathan R., Lu K.P., Hunter T., Noel J.P. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell. 89:1997;875-886.
5. Somlyo A.P., Somlyo A.V. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol, (London). 522:2000;177-185.
6. Hartshorne D.J., Ito M., Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J. Muscle Res. Cell Motil. 19:1998;325-341.
7. 2+ sensitization in smooth muscle. Biophys. J. 82:2002;421e.
8. Woodsome T.P., Eto M., Kitazawa T. Characterization and localization of CPI-17 in arterial smooth muscle cells. Biophys. J. 82:2002;419c.
9. Kitazawa T., Eto M., Woodsome T.P., Brautigan D.L. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J. Biol. Chem. 275:2000;9897-9900.
10. Etter E.F., Eto M., Wardle R.L., Brautigan D.L., Murphy R.A. Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J. Biol. Chem. 276:2001;34681-34685.
11. Eto M., Ohmori T., Suzuki M., Furuya K., Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J. Biochem. 118:1995;1104-1107.
12. Eto M., Senba S., Morita F., Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Letters. 410:1997;356-360.
13. Eto M., Kitazawa T., Yazawa M., Mukai H., Ono Y., Brautigan D.L. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphoatase by protein kinase C alpha and delta isoforms. J. Biol. Chem. 276:2001;29072-29078.
14. Hayashi Y., Senba S., Yazawa M., Brautigan D.L., Eto M. Defining the structural determinants and a potential mechanism for inhibition of myosin phosphatase by the protein kinase C-potentiated inhibitor protein of 17 kDa. J. Biol. Chem. 276:2001;39858-39863.
15. Ohki S., Eto M., Kariya E., Hayano T., Hayashi Y., Yazawa M., et al. Structure of the myosin phosphatase inhibitor protein CPI- 17 shows phosphorylation-induced conformational changes responsible for activation. J. Mol. Biol. 314:2001;839-849.
16. Kainosho M. Isotope labelling of macromolecules for structural determinations. Nature Struct. Biol. 4 Suppl:1997;858-861.
17. Huang F.L., Glinsmann W.H. Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur. J. Biochem. 70:1976;419-426.
18. Hemmings H.C., Greengard P., Lim H.Y., Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature. 310:1984;503-505.
19. Beullens M., Van Eynde A., Stalmans W., Bollen M. The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. J. Biol. Chem. 267:1992;16538-16544.
20. Shirato H., Shima H., Sakashita G., Nakano T., Ito M., Lee E.Y., Kikuchi K. Identification and characterization of a novel protein inhibitor of type 1 protein phosphatase. Biochemistry. 39:2000;13848-13855.
21. Eto M., Karginov A., Brautigan D.L. A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzyme. Biochemistry. 38:1999;16952-16957.
22. Deng J.T., Sutherland C., Brautigan D.L., Eto M., Walsh M.P. Phosphorylation of the myosin phosphatase inhibitors CPI-17 and PHI-1, by integrin-linked kinase. Biochem. J. 29:2002;517-524.
23. Liu Q.R., Zhang P.W., Zhen Q., Walther D., Wang X.B., Uhl G.R. KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphine. J. Biol. Chem. 277:2002;13312-13320.
24. Richardson J.S. The anatomy and taxonomy of protein structure. Advan. Protein Chem. 34:1981;167-339.
25. Presnell S.R., Cohen F.E. Topological distribution of four-a-helix bundles. Proc. Natl Acad. Sci. USA. 86:1989;6586-6652.
26. Dhalluin C., Carlson J.E., Zheng L., He C., Aggarwal A.K., Zhou M.M. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 399:1999;491-496.
27. Bax A., Pochapsky S.S. Optimized recording of heteronuclear multidimensional NMR spectra using pulsed field gradients. J. Magn. Reson. 99:1992;638-643.
28. Kay L.E., Keifer P. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114:1992;10663-10665.
29. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Clore M. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 6:1995;277-293.
30. Garrett D.S., Powers R., Gronenborn A.M., Clore M. A commonsense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams. J. Magn. Reson. 95:1991;214-220.
31. Brünger, A. T. (1992). X-PLOR, a system for X-ray crystallography and NMR, New Haven, Yale University Press, New Haven, CT.
32. Laskowski R.A., et al. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8:1996;477-486.
33. Koradi R., Billeter M., Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:1996;51-55.
34. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
35. Merrit E.A., Bacon D.J. Raster 3D: photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524.
36. Friedenauer S., Berlet H.H. Sensitivity and variability of the Bradford protein assay in the presence of detergents. Anal. Biochem. 178:1989;263-268.